life science organizations
Moving Beyond the Pill: Unlocking Value Through Engaged, Empowered, and Educated Patients
True "beyond-the-pill" strategy requires shifting from a prescriptive model to a supportive one—using personalized digital tools and authentic patient voices to drive adherence, improve outcomes, and prove value.
It’s time to stop calling adverse events ‘manageable’
A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.
Where translation falls short in practice
Discover why translation alone is not enough in global clinical trials and how expert localisation improves participant understanding, trust and engagement.
J&J’s Erleada prostate cancer study shows significant reduction in risk of metastasis
Erleada plus hormone therapy significantly improved key short- and long-term clinical outcomes
UK clinical trial regs are changing — here’s what’s happening
Discover the transformative updates to UK clinical trial regulations, effective from April 2026, and learn how they aim to enhance transparency, participant safety, and trial efficiency.
Atrogi moves forward in phase 1 trial for oral candidate to improve metabolic and muscle health
First-in-class oral therapy mimics the effects of exercise with broad potential as a novel treatment for muscle-sparing weight loss
Smarter Learning and Better Outcomes: How AI Can Provide an Advantage in Medical Education
See how AI-powered patient avatars allow physicians to test complex diagnoses and treatment plans in a simulated environment.
LEO Pharma’s Anzupgo cream progresses to phase 3 trial for lichen sclerosus
There are currently no approved treatments specifically indicated for LS in the US or Europe
Novo Nordisk announces positive results for CagriSema in type 2 diabetes
CagriSema improved weight loss and blood glucose control compared to semaglutide alone across all tested doses
New Webinar: 2026 Engagement Strategies For Modern Pharma
Turn interaction into intelligence! Don’t miss this chance to lead the industry with our free pharma-exclusive webinar!
Major prostate cancer screening trial launched in UK
The £42m Transform trial will recruit men aged 50-74, with a lower age limit of 45 for some men
Physician-driven, AI-supported: addressing the clinical trial access gap
To open up more clinical paths for patients, HCPs need simpler search tools, better access to information and integrated referral systems that fit into their clinical workflows